A detailed history of Deep Track Capital, LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Deep Track Capital, LP holds 1,350,000 shares of CNTA stock, worth $22.9 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
1,350,000
Holding current value
$22.9 Million
% of portfolio
0.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $11.6 Million - $22.9 Million
1,350,000 New
1,350,000 $21.6 Million
Q1 2022

May 16, 2022

SELL
$7.45 - $11.59 $2.98 Million - $4.64 Million
-400,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$10.99 - $17.54 $4.4 Million - $7.02 Million
400,000 New
400,000 $4.5 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.6B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.